# ENDO USA, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/endo-usa-inc/f2df2e47-8303-4a2c-9881-5e2ecef64f22

> Inspection records and compliance data for ENDO USA, Inc. in Rochester, Michigan. Access full analysis and detailed observations.

---

## Details

- Name: ENDO USA, Inc.
- FEI Number: 1818977
- City: Rochester
- State: Michigan
- Country Name: United States
- Address Line 1: 870 Parkdale Rd
- Zip Code: 48307
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - ENDO USA, Inc. - Unknown Date](https://www.keypedia.com/records/483/endo-usa-inc/cd434a60-f760-4174-bc93-90d668d3e834) — source: FDA, date: Invalid Date
- [483 - ENDO USA, Inc. - 2025-10-20](https://www.keypedia.com/records/483/endo-usa-inc/2f9d2320-d4c6-4b06-9da5-5a58dc371f64) — source: FDA, date: October 20, 2025
- [FDA Inspection 1287690 - ENDO USA, Inc. - 2025-10-20](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/a79ee286-4307-4f74-aea2-015891503ef7) — classification: Official Action Indicated (OAI), source: FDA, date: October 20, 2025
- [FDA Inspection 1287690 - ENDO USA, Inc. - 2025-10-20](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/b5f733a6-5903-4ef1-91da-486952bf0268) — classification: Official Action Indicated (OAI), source: FDA, date: October 20, 2025
- [FDA Inspection 1287690 - ENDO USA, Inc. - 2025-10-20](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/93857a84-c2b3-4b8b-bd9d-ee936a19f95c) — source: FDA, date: October 20, 2025
- [FDA Inspection 1287690 - ENDO USA, Inc. - 2025-10-20](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/6f6443a1-f96e-415e-b0cb-52567260b427) — classification: Official Action Indicated (OAI), source: FDA, date: October 20, 2025
- [483 - ENDO USA, Inc. - 2025-06-05](https://www.keypedia.com/records/483/endo-usa-inc/aaf10327-fc58-4ce7-9174-f165fd8d9972) — source: FDA, date: June 5, 2025
- [483 - ENDO USA, Inc. - 2025-06-05](https://www.keypedia.com/records/483/endo-usa-inc/47c8a26f-ab58-4b6b-b78a-4e26fd6d36c3) — source: FDA, date: June 5, 2025
- [FDA Inspection 1256071 - ENDO USA, Inc. - 2025-06-05](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/3cdab831-b037-4ab8-979c-4f66eef17a21) — source: FDA, date: June 5, 2025
- [FDA Inspection 1256071 - ENDO USA, Inc. - 2025-06-05](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/319f1250-cfd1-4256-b8bf-1703122dfae3) — source: FDA, date: June 5, 2025
- [483 - ENDO USA, Inc. - 2023-04-14](https://www.keypedia.com/records/483/endo-usa-inc/a95cae7d-511c-43d5-81a1-dba506cb0c81) — source: FDA, date: April 14, 2023
- [483 - ENDO USA, Inc. - 2023-04-14](https://www.keypedia.com/records/483/endo-usa-inc/51dea78b-5586-447a-a96e-6d6017dfe49d) — source: FDA, date: April 14, 2023
- [FDA Inspection 1202528 - ENDO USA, Inc. - 2023-04-14](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/d06e5359-bb7a-49b3-bd69-de58e8bc4981) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 14, 2023
- [FDA Inspection 1155650 - ENDO USA, Inc. - 2021-10-22](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/8afcf877-bd2d-4f81-b59b-0f27f7498c1e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2021
- [FDA Inspection 1155650 - ENDO USA, Inc. - 2021-10-22](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/652dab12-0089-421f-87e6-b40a3d772bf7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2021
- [483 - ENDO USA, Inc. - 2021-10-18](https://www.keypedia.com/records/483/endo-usa-inc/bc42b7b8-b606-43d6-9f83-1afe317d5482) — source: FDA, date: October 18, 2021
- [483 - ENDO USA, Inc. - 2019-04-15](https://www.keypedia.com/records/483/endo-usa-inc/35e87fe3-12a5-4f62-8497-b112609447cd) — source: FDA, date: April 15, 2019
- [FDA Inspection 1086628 - ENDO USA, Inc. - 2019-04-15](https://www.keypedia.com/records/fda_inspections/endo-usa-inc/e172d095-89d8-4074-9fce-808aeee6dad7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 15, 2019
- [483 - ENDO USA, Inc. - 2018-08-09](https://www.keypedia.com/records/483/endo-usa-inc/b6ded9a6-e663-4d93-856a-a7860d06a8fe) — source: FDA, date: August 9, 2018
- [483 - ENDO USA, Inc. - 2010-08-31](https://www.keypedia.com/records/483/endo-usa-inc/d670c0c9-7a93-4508-a39b-e5bdb8059c15) — source: FDA, date: August 31, 2010

## Related Companies

- [King Pharmaceuticals LLC](https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5)
- [JHP Pharmaceuticals, LLC](https://www.keypedia.com/companies/jhp-pharmaceuticals-llc/06142290-74aa-43ad-a58a-04d02c7e07f7)
- [The Home City Ice Company](https://www.keypedia.com/companies/the-home-city-ice-company/f66abac9-d1e4-4eea-b02a-3658c5abfe5a)
- [Tracinas Gourmet Specialties](https://www.keypedia.com/companies/tracinas-gourmet-specialties/20156c4c-c5c0-4173-a910-132b57d5ee73)

## Related Officers

- [Associate Director](https://www.keypedia.com/people/jeffrey-d-meng/55543677-bd74-4cc5-8a2a-e14afb91d338)
- [Michele L. Forster](https://www.keypedia.com/people/michele-l-forster/5e4b6db7-412f-4e4f-87a9-8af15a16429f)
- [CSO](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)
- [issuing_officer](https://www.keypedia.com/people/omotunde-osunsanmi/41c6ef66-1d5c-4940-8b1f-628da20cde34)
- [Amy Graf](https://www.keypedia.com/people/amy-graf/0d21b7b0-0137-47a1-b014-70e7391bc845)
- [investigator](https://www.keypedia.com/people/joseph-t-madak/85a0e12a-6130-4f04-91ee-bb5351081b8a)